Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Acute and subacute iridocyclitis |
French
|
Iridocyclite aiguë et subaiguë |
| Level | Code | Title | |
|---|---|---|---|
| 1 | VII | Diseases of the eye and adnexa | |
| 2 | H15-H22 | Disorders of sclera, cornea, iris and ciliary body | |
| 3 | H20 | Iridocyclitis | |
| 4 | H20.0 | Acute and subacute iridocyclitis |
| Active Ingredient | Description | |
|---|---|---|
| Adalimumab |
Adalimumab binds specifically to TNF and neutralizes the biological function of TNF by blocking its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab also modulates biological responses that are induced or regulated by TNF, including changes in the levels of adhesion molecules responsible for leukocyte migration (ELAM-1, VCAM-1, and ICAM-1 with an IC50 of 0.1-0.2 nM). |
|
| Atropine |
Atropine is an antimuscarinic agent which competitively antagonises acetylcholine at postganglionic nerve endings, thus affecting receptors if the exocrine glands, smooth muscle, cardiac muscle and the central nervous system. |
|
| Methylprednisolone |
Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system. |
